LY2828360

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2828360, covering 2020-05-19 to 2020-05-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2828360 in Patients With Osteoarthritic Knee Pain [Phase 2]